We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Next Generation PillCam Offers Improved Technology

By HospiMedica International staff writers
Posted on 04 Sep 2013
The new generation PillCam provides a more detailed and efficient small bowel (SB) examination for patients with conditions such as obscure gastroitenstinal bleeding (OGIB).

The PillCam SB 3 capsule is used to visualize and monitor SB abnormalities associated with Crohn's disease (CD), iron deficiency anemia (IDA) and OGIB. More...
The PillCam measures 11 x 26 mm, and weighs less than four grams. The third generation PillCam contains an imaging device and light source, transmitting images at a rate of two and six images per second, providing an accurate, patient-friendly tool for patients two years and older. The PillCam SB 3 builds on the experience garnered from more than two million uses of PillCam capsules in patients worldwide and more than 1,900 clinical studies since 2001.

The PillCam SB 3 system combines a 30% improvement in image resolution with adaptive frame rate technology to deliver more detailed SB images and coverage than the PillCam SB 2. In addition, PillCam SB 3's video processing engine has been significantly improved, and proprietary algorithms in the system's new software enable smarter video compilation that is 40% more efficient than PillCam SB 2. The PillCam SB 3 system is a product of Given Imaging (Yokneam, Israel), and has been approved by the US Food and Drug Administration (FDA).

“With more than two million procedures conducted since the first generation of the product was introduced, PillCam SB has had a significant impact on patient care in the US and across the globe,” said Homi Shamir, president and CEO of Given Imaging. “We believe PillCam SB 3 will both enhance the clinical experience for our large base of existing US customers and expand the market for this product among new physicians who have not been performing PillCam procedures.”

“Patients with complicated diseases involving the small bowel, such as Crohn's disease, often struggle to comprehend what is happening inside their bodies and how it can be better managed,” said Felice H. Schnoll-Sussman, MD, director of the Jay Monahan Center for Gastrointestinal Health at New York-Presbyterian Weill Cornell Medical Center (NY, USA). “The improved image resolution and overall efficiency of the PillCam SB 3 system in capturing and analyzing images of the small bowel has potential to have a meaningful impact on patient care.”

Related Links:

Given Imaging



Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Medical Monitor
VITALMAX 4100SL
Infrared Digital Thermometer
R1B1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.